Home

Vandaliser engagement Moi vas narasimhan repousser Ne fais pas ça transfusion

It was never my plan to be the boss of a huge company' - BBC News
It was never my plan to be the boss of a huge company' - BBC News

BSR Conference 2018 | Vasant Narasimhan | Speakers
BSR Conference 2018 | Vasant Narasimhan | Speakers

Interview: Vas Narasimhan, the 'unboss' of Novartis | Business | The Sunday  Times
Interview: Vas Narasimhan, the 'unboss' of Novartis | Business | The Sunday Times

Vas Narasimhan on Twitter: "It was great to spend time with the students at  @PriorySouthsea this week! https://t.co/YPZTvVHuUt" / Twitter
Vas Narasimhan on Twitter: "It was great to spend time with the students at @PriorySouthsea this week! https://t.co/YPZTvVHuUt" / Twitter

Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' -  The New York Times
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times

CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a  mistake he's determined to overcome | Fierce Pharma
CEO Vas Narasimhan tells employees Novartis' deal with Trump lawyer was a mistake he's determined to overcome | Fierce Pharma

novartis: Who is Vas Narasimhan? All about the new global chief executive  of Swiss pharma giant Novartis - The Economic Times
novartis: Who is Vas Narasimhan? All about the new global chief executive of Swiss pharma giant Novartis - The Economic Times

Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT |  Fierce Pharma
Vas Narasimhan knew what to expect as Novartis CEO—or so he thought: NYT | Fierce Pharma

Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash  | Barron's
Novartis CEO Vasant Narasimhan Sees Consistent Growth While Sitting on Cash | Barron's

Novartis sees strong interest in Sandoz generics unit - Finanz und  Wirtschaft | Reuters
Novartis sees strong interest in Sandoz generics unit - Finanz und Wirtschaft | Reuters

Watch CNBC's full interview with Novartis CEO Vas Narasimhan - YouTube
Watch CNBC's full interview with Novartis CEO Vas Narasimhan - YouTube

Novartis's Vas Narasimhan on AI, Data Science for Company Operations
Novartis's Vas Narasimhan on AI, Data Science for Company Operations

Transforming Standards Of Patient Care And Unbossing The Organisation With  Novartis CEO Vas Narasimhan - Outside Lens
Transforming Standards Of Patient Care And Unbossing The Organisation With Novartis CEO Vas Narasimhan - Outside Lens

Novartis CEO in the hotseat after revelation that his company submitted  falsified data to the FDA - The Boston Globe
Novartis CEO in the hotseat after revelation that his company submitted falsified data to the FDA - The Boston Globe

Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company -  YouTube
Novartis CEO Vas Narasimhan: How to be a boss in an “unbossed” company - YouTube

Watch CNBC's full interview with Novartis CEO Vas Narasimhan
Watch CNBC's full interview with Novartis CEO Vas Narasimhan

Novartis' growth ills lay tricky treatment pathway | Reuters
Novartis' growth ills lay tricky treatment pathway | Reuters

Managing My Energy, Not My Time
Managing My Energy, Not My Time

Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion  Annually | Barron's
Novartis CEO Continues Shake-Up, Says Will Save More Than $1 Billion Annually | Barron's

Vasant Narasimhan - Wikipedia
Vasant Narasimhan - Wikipedia

Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New  Technology
Novartis CEO Vas Narasimhan on M&A and Taking Earlier Risks on New Technology

Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' -  The New York Times
Vas Narasimhan of Novartis: 'We Are Not at All Prepared for a Pandemic' - The New York Times

Novartis' CEO on gene therapy, innovation, and the company pivot - STAT
Novartis' CEO on gene therapy, innovation, and the company pivot - STAT

Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are  working to help more people get access to the medicines they need  #AccessinAction | Facebook
Novartis - Speaking at #BSR18, our CEO Vas Narasimhan shares how we are working to help more people get access to the medicines they need #AccessinAction | Facebook

Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on  sales | Fierce Pharma
Novartis CEO's 2020 pay drops to $11.6M, no thanks to COVID-19's drag on sales | Fierce Pharma